Utility of susceptibility-weighted MRI in differentiating Parkinson's disease and atypical parkinsonism

Neuroradiology

Volumn 52, Issue 12, 2010, Pages 1087-1094

  Gupta, Deepak ^a   Saini, Jitender ^a   Kesavadas, Chandrasekharan ^a   Sarma, P Sankara ^a   Kishore, Asha ^a  

^a SREE CHITRA TIRUNAL INSTITUTE FOR MEDICAL SCIENCES AND TECHNOLOGY   (India)

Author keywords

Multiple System Atrophy; Parkinson's disease; Progressive Supra Nuclear Palsy; SWI

Indexed keywords

ADULT; ARTICLE; BIOMINERALIZATION; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DENTATE NUCLEUS; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; FEMALE; HUMAN; IMAGE ANALYSIS; INTERRATER RELIABILITY; INTRARATER RELIABILITY; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PARKINSONISM; PILOT STUDY; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PUTAMEN; RATING SCALE; RED NUCLEUS; SCORING SYSTEM; SHY DRAGER SYNDROME; SUBSTANTIA NIGRA;

BRAIN; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PARKINSON DISEASE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 78650009796     PISSN: 00283940     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00234-010-0677-6     Document Type: Article

References (40)

1. WRG Gibb AJ Lees 1988 The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease J Neurol Neurosurg Psychiatry 51 745 752 1:STN:280:DyaL1czgtVSqsg%3D%3D 10.1136/jnnp.51.6.745 2841426
2. S Gilman P Low N Quinn, et al. 1998 Consensus criteria on the diagnosis of multiple system atrophy Clin Auton Res 8 359 362 1:STN:280: DyaK1M%2FosV2jsg%3D%3D 10.1007/BF02309628 9869555 (Pubitemid 29021108)
3. I Litvan 2001 Diagnosis and management of progressive supranuclear palsy Semin Neurol 21 41 48 1:STN:280:DC%2BD3M3ltVWnuw%3D%3D 10.1055/s-2001-13118 11346024
4. I Litvan KP Bhatia DJ Burn, et al. 2003 SIC task force appraisal of clinical diagnostic criteria for parkinsonian disorders Mov Disord 18 467 486 10.1002/mds.10459 12722160 (Pubitemid 36656531)
5. A Schrag CD Good K Miszkiel, et al. 2000 Differentiation of atypical parkinsonian syndromes with routine MRI Neurology 54 697 702 1:STN:280:DC%2BD3c7kt12quw%3D%3D 10680806
6. K Seppi MFH Schocke 2005 An update on conventional and advanced MRI techniques in the differential diagnosis of neurodegenerative parkinsonism Curr Opin Neurol 18 370 375 10.1097/01.wco.0000173141.74137.63 16003111
7. F Yekhlef G Ballan F Macia O Delmer C Sourgen F Tison 2003 Routine MRI for the differential diagnosis of Parkinson's disease, MSA, PSP and CBD J Neural Transm 110 151 169 1:STN:280:DC%2BD3s%2FnvVWktg%3D%3D 10.1007/s00702-002-0785-5 12589575 (Pubitemid 36216498)
8. H Oba A Yagishita H Terada, et al. 2005 New and reliable MRI diagnosis for progressive supranuclear palsy Neurology 64 2050 2055 1:STN:280: DC%2BD2MzjsFSgtw%3D%3D 10.1212/01.WNL.0000165960.04422.D0 15985570 (Pubitemid 40880991)
9. SJ Huber DW Chakeres GW Paulson R Khanna 1990 Magnetic resonance imaging in Parkinson's disease Arch Neurol 47 735 737 1:STN:280:DyaK3c3ptVeksw%3D%3D 2357153
10. MFH Schocke K Seppi R Esterhammer, et al. 2002 Diffusion-weighted MRI differentiates the Parkinson variant of multiple system atrophy from PD Neurology 58 575 580 1:STN:280:DC%2BD387ivFSgtQ%3D%3D 11865135
11. K Seppi MFH Schocke R Esterhammer, et al. 2003 Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the Parkinson variant of multiple system atrophy Neurology 60 922 927 1:STN:280:DC%2BD3s7ktVWnuw%3D%3D 10.1001/archneur.60.7.922 12654954
12. G Nicoletti R Lodi F Condino, et al. 2006 Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclear palsy Brain 129 2679 2687 10.1093/brain/awl166 16815875 (Pubitemid 44522101)
13. DC Paviour JS Thornton AJ Lees HR Jager 2007 Diffusion-weighted magnetic resonance imaging differentiates parkinsonian variant of multiple-system atrophy from progressive supranuclear palsy Mov Disord 22 68 74 10.1002/mds.21204 17089396 (Pubitemid 46382675)
14. CRV Blain GJ Barker JM Jarosz, et al. 2006 Measuring brain stem and cerebellar damage in parkinsonian syndromes using diffusion tensor MRI Neurology 67 2199 2205 1:STN:280:DC%2BD28jltlKhtg%3D%3D 10.1212/01.wnl.0000249307.59950. f8 17190944 (Pubitemid 46035477)
15. CA Davie GK Wenning GJ Barker, et al. 1995 Differentiation of multiple system atrophy from idiopathic Parkinson's disease using proton magnetic resonance spectroscopy Ann Neurol 37 204 210 1:STN:280:DyaK2M7ltVGnsg%3D%3D 10.1002/ana.410370211 7847862
16. F Federico IL Simone V Lucivero, et al. 1997 Proton magnetic resonance spectroscopy in Parkinson's disease and atypical parkinsonian disorders Mov Disord 12 903 909 1:STN:280:DyaK1c%2FmtFKisw%3D%3D 10.1002/mds.870120611 9399213 (Pubitemid 27496766)
17. T Eckert M Sailer J Kaufmann, et al. 2004 Differentiation of idiopathic Parkinson's disease, multiple system atrophy, progressive supranuclear palsy and healthy controls using magnetization transfer imaging NeuroImage 21 229 235 10.1016/j.neuroimage.2003.08.028 14741660 (Pubitemid 38115013)
18. JB Schulz M Skalej D Wedekind, et al. 1999 Magnetic resonance imaging based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy Ann Neurol 45 65 74 1:STN:280:DyaK1M7htVWksg%3D%3D 10.1002/1531-8249(199901)45:1<65::AID- ART12>3.0.CO;2-1 9894879 (Pubitemid 29036434)
19. SL Harder KM Hopp H Ward H Neglio J Gitlin D Kido 2008 Mineralization of the deep gray matter with age: a retrospective review with susceptibility- weighted MR imaging AJNR 29 176 183 1:STN:280:DC%2BD1c%2Fis1SnsA%3D%3D 10.3174/ajnr.A0770 17989376
20. V Sehgal Z Delproposto EM Haacke, et al. 2005 Clinical applications of neuroimaging with susceptibility-weighted imaging J Magn Reson Imaging 22 439 450 10.1002/jmri.20404 16163700 (Pubitemid 41416402)
21. DT Dexter P Jenner AHV Schapira CD Marsden 1992 Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia Ann Neurol 32 S94 S100 1:CAS:528:DyaK3sXltVSi 10.1002/ana.410320716 1510387
22. QF Ye SP Allen WWR Martin 1996 Basal ganglia iron content in Parkinson's disease measured with magnetic resonance Mov Disord 11 243 249 1:STN:280:DyaK28zgtVCrug%3D%3D 10.1002/mds.870110305 8723139 (Pubitemid 26138821)
23. PD Burton O Warren P Burger A Johnson R Herfkens S Riederer 1986 Parkinson plus syndrome: diagnosis using high field MR imaging of brain iron Radiology 159 493 498
24. AJ Hughes SE Daniel Y Ben Shlomo AJ Lees 2002 The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service Brain 1254 861 870 10.1093/brain/awf080
25. Fahn S, Elton RL, Members of the UPDRS Development Committee (1987) Unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Calne D, Goldstein M (eds) Recent developments in Parkinson's disease. Macmillan Health Care Information, Florham Park, pp 153-163
26. MF Folstein SE Folstein PR Mc Hugh 1975 Mini-Mental State: a practical method for grading the cognitive stat of patients for the clinical J Psyhciatr Res 12 189 198 1:STN:280:DyaE28%2FntFKjtw%3D%3D 10.1016/0022-3956(75)90026-6
27. EM Haacke Y Xu YC Cheng JR Reichenbach 2004 Susceptibility weighted imaging (SWI) Magn Reson Med 52 612 618 10.1002/mrm.20198 15334582 (Pubitemid 39108975)
28. B Thomas S Somasundaram K Thamburaj, et al. 2008 Clinical applications of susceptibility weighted MR imaging of the brain-a pictorial review Neuroradiology 50 105 116 10.1007/s00234-007-0316-z 17929005 (Pubitemid 351171454)
29. SJ Collins JE Ahlskog JE Parisi DM Maraganore 1995 Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria J Neurol Neurosurg Psychiatry 58 167 173 1:STN:280:DyaK2M7ot1Witw%3D%3D 10.1136/jnnp.58.2.167 7876846
30. AE Lang MA Lozano 1998 Parkinson's disease-first of two parts N Engl J Med 339 1044 1053 1:STN:280:DyaK1cvisFKmsg%3D%3D 10.1056/NEJM199810083391506 9761807 (Pubitemid 28457867)
31. GK Wenning F Tison Y Ben-Shlomo SE Daniel NP Quinn 1997 Multiple system atrophy: a review of 203 pathologically proven cases Mov Disord 12 133 147 1:STN:280:DyaK2s3kt12qsw%3D%3D 10.1002/mds.870120203 9087971 (Pubitemid 27152018)
32. EM Haacke NY Cheng MJ House, et al. 2005 Imaging iron stores in the brain using magnetic resonance imaging Magn Reson Imaging 23 1 25 1:CAS:528:DC%2BD2MXhslWmtL0%3D 10.1016/j.mri.2004.10.001 15733784 (Pubitemid 40269946)
33. M Gerlach D Ben-Shachar P Riederer MB Youdim 1994 Altered brain metabolism of iron as a cause of neurodegenerative diseases? J Neurochem 63 793 807 1:CAS:528:DyaK2cXlsFCgtLo%3D 10.1046/j.1471-4159.1994.63030793.x 7519659
34. F von Lewinski C Werner T Jörn A Mohr F Sixel-Döring C Trenkwalder, et al. 2007 T2*-weighted MRI in diagnosis of multiple system atrophy J Neurol 254 1184 1188 10.1007/s00415-006-0496-1 (Pubitemid 350112344)
35. B Hallgren P Sourander 1958 The effect of age on the non-haemin iron in the human brain J Neurochem 3 41 51 1:CAS:528:DyaG1MXlslCluw%3D%3D 10.1111/j.1471-4159.1958.tb12607.x 13611557
36. WWR Martin FQ Ye PS Allen 1998 Increasing striatal iron content associated with normal aging Mov Disord 13 281 286 1:STN:280: DyaK1c7pvVOnug%3D%3D 10.1002/mds.870130214 9539342 (Pubitemid 28127804)
37. E Kraft C Trenkwalder PD Auer 2002 T2*-weighted MRI differentiates multiple system atrophy from Parkinson's disease Neurology 59 1265 1267 12391363
38. N Gelman JM Gorell PB Barker, et al. 1999 MR imaging of human brain at 3.0 T: preliminary report on transverse relaxation rates and relation to estimated iron content Radiology 210 759 767 1:STN:280:DyaK1M3itlyrtA%3D%3D 10207479
39. G Bartzokis J Mintz D Sultzer, et al. 1994 In vivo MR evaluation of age-related increases in brain iron AJNR 15 1129 1138 1:STN:280: DyaK2czlsVSmtA%3D%3D 8073983
40. JR Reichenbach R Venkatesan DA Yablonskiy, et al. 1997 Theory and application of static field inhomogeneity effects in gradient-echo imaging J Magn Reson Imaging 7 266 279 1:STN:280:DyaK2s3ksF2gtQ%3D%3D 10.1002/jmri. 1880070203 9090577 (Pubitemid 28356957)